AKT1 and thyroid cancer: Dysfunction of these pathways contributes to many diseases, such as malignant tumours, and some studies have reported that thyroid cancer patients show abnormal activation of PI3K/AKT signalling, which may provide useful therapeutic targets for thyroid cancer [27].